1. Home
  2. OLMA vs PAYS Comparison

OLMA vs PAYS Comparison

Compare OLMA & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • PAYS
  • Stock Information
  • Founded
  • OLMA 2006
  • PAYS 1995
  • Country
  • OLMA United States
  • PAYS United States
  • Employees
  • OLMA N/A
  • PAYS 123
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • PAYS Business Services
  • Sector
  • OLMA Health Care
  • PAYS Consumer Discretionary
  • Exchange
  • OLMA Nasdaq
  • PAYS Nasdaq
  • Market Cap
  • OLMA 465.4M
  • PAYS 160.1M
  • IPO Year
  • OLMA 2020
  • PAYS 1998
  • Fundamental
  • Price
  • OLMA $6.10
  • PAYS $2.99
  • Analyst Decision
  • OLMA Strong Buy
  • PAYS Strong Buy
  • Analyst Count
  • OLMA 5
  • PAYS 3
  • Target Price
  • OLMA $26.25
  • PAYS $6.17
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • PAYS 169.3K
  • Earning Date
  • OLMA 11-12-2024
  • PAYS 11-05-2024
  • Dividend Yield
  • OLMA N/A
  • PAYS N/A
  • EPS Growth
  • OLMA N/A
  • PAYS 368.11
  • EPS
  • OLMA N/A
  • PAYS 0.14
  • Revenue
  • OLMA N/A
  • PAYS $56,467,600.00
  • Revenue This Year
  • OLMA N/A
  • PAYS $25.62
  • Revenue Next Year
  • OLMA N/A
  • PAYS $13.23
  • P/E Ratio
  • OLMA N/A
  • PAYS $21.59
  • Revenue Growth
  • OLMA N/A
  • PAYS 27.75
  • 52 Week Low
  • OLMA $5.56
  • PAYS $2.40
  • 52 Week High
  • OLMA $16.78
  • PAYS $5.59
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • PAYS 30.52
  • Support Level
  • OLMA $5.56
  • PAYS $2.81
  • Resistance Level
  • OLMA $6.87
  • PAYS $3.17
  • Average True Range (ATR)
  • OLMA 0.81
  • PAYS 0.14
  • MACD
  • OLMA -0.28
  • PAYS -0.02
  • Stochastic Oscillator
  • OLMA 10.12
  • PAYS 21.33

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About PAYS Paysign Inc.

PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized, payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.

Share on Social Networks: